ConductScience.org, home

Trial · NCT01222247

Registered outcomes29

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNeonatal Composite Outcome72 hours of life
Need for respiratory support: Continuous positive airway pressure (CPAP) or humidified high-flow nasal cannula (HHFNC) for greater than or equal to 2 hours or more in the first 72 hours, or fraction of inspired oxygen (FiO2) greater than or equal to 0.30 for 4 hours or more in the first 72 hours, or mechanical ventilation in the first 72 hours, or Extracorporeal membrane oxygenation (ECMO) Stillbirth, or neonatal death less than 72 hours of age
SecondaryNumber of Neonates With Severe Respiratory Complication,72 hours of life
A severe respiratory complication was defined as any of the following occurrences within 72 hours after birth: CPAP or high-flow nasal cannula for at least 12 hours, supplemental oxygen with a fraction of inspired oxygen of 0.30 or more for at least 24 hours, mechanical ventilation, stillbirth or neonatal death, or the need for ECMO. Except for the duration of CPAP or high-flow nasal cannula and the duration of a fraction of inspired oxygen of 0.30 or more, the criteria for a severe respiratory complication overlap with those of the primary outcome.
SecondaryNeonates Needing Immediate Resuscitation After BirthWithin the first 30 minutes of birthNeed for resuscitation after birth: any intervention in the first 30 minutes other than blow-by oxygen
SecondaryNumber of Neonates With Respiratory Distress SyndromeDelivery
Respiratory distress defined as the presence of clinical signs of respiratory distress (tachypnea, retractions, flaring, grunting, or cyanosis) with an oxygen requirement and a chest x-ray that shows hypoaeration and reticulogranular infiltrates
SecondaryNumber of Neonates With Transient Tachypnea of the Newbornby 72 hours after delivery
TTN is defined as signs of respiratory distress, specifically tachypnea, that are resolved by 72 hours of age. TTN may be diagnosed in the absence of a chest X-ray or with a chest X-ray that is normal or shows signs of increased perihilar interstitial markings
SecondaryNumber of Infants With Neonatal Apnea72 hours of lifeNeonatal apnea with respiratory pauses of more than 20 seconds duration resulting in bradycardia or oxygen desaturation below baseline.
SecondaryNumber of Infants withChronic Lung Disease / Bronchopulmonary Dysplasia (BPD) Requiring Supplemental Oxygen28 days of lifeInfants requiring supplemental oxygen of more than 0.21 for the first 28 days of life
SecondaryNeonates With Pneumoniaby 72 hours of lifeNeonatal pneumonia
SecondaryNumber of Neonates Needing Surfactant AdministrationDeliveryAdministration of surfactant for neonatal respiratory treatment
SecondaryNeonatal Outcome Composite72 hours of lifeTransient tachypnea of the newborn (TTN), respiratory distress syndrome (RDS), and apnea
SecondaryNumber of Neonates With Pulmonary Air Leak72 hours post deliveryNeonatal pulmonary air leak syndrome
SecondaryNeonatal Death After 72 Hours of Delivery72 hours after delivery through hospital discharge up to 3 weeksNeonatal death after 72 hours of life but before hospital discharge.
SecondaryBirth WeightDeliveryWeight in grams at delivery
SecondaryBirth Weight Less Than 10th PercentileDeliveryNeonates whose birth weight is less than the 10th percentile at delivery
SecondaryGestational Age at DeliveryDelivery
Number of neonates delivered at ≤ 34 weeks 6 days, between 35 weeks 0 days and 35 weeks 6 days, between 36 weeks 0 days and 36 weeks 6 days, between 37 weeks 0 days and 38 weeks 6 days, or on or after 39 weeks 0 days
SecondaryNumber of Neonates With Necrotizing Enterocolitic (NEC)Delivery
Defined as modified Bell Stage 2 or 3. Stage 2: Clinical signs and symptoms with pneumatosis intestinalis on radiographs. Stage 3: Advanced clinical signs and symptoms, pneumatosis, impending or proven intestinal perforation.
SecondaryNumber of Infants With Neonatal SepsisDelivery
Clinical suspicion of systemic infection with a positive blood, cerebral spinal fluid, or catheterized/suprapubic urine culture; or, in the absence of positive cultures, clinical evience of cardiovascular collapse or an X-ray confirming infection.
SecondaryNumber of Neonates With Intraventricular HemorrhageDeliveryGrade 3 or 4 Intraventricular Hemorrhage
SecondaryNeonatal Morbidity CompositeDeliveryA composite endpoint of morbidities known to be affected by steroid administration will also be evaluated. Specifically, this composite will include RDS, intraventricular hemorrhage (IVH), and NEC
SecondaryNumber of Neonates With HypoglycemiaDelivery through hospital discharge up to 3 weeksGlucose \< 40 mg per deciliter (2.2 mmol per liter) at any time

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01222247/registered